Research
Augmenting sirtuin activity to drive cartilage regeneration and treat osteoarthritis.
Principal investigator: | David LEE |
Co-investigator(s): | and Paul Caton |
Funding source(s): | Dunhill Medical Trust |
| Start: 01-11-2014 / End: 31-12-2016 |
| Amount: £150,201 |
Osteoarthritis (OA) is a highly prevalent disease involving degeneration of articular cartilage and chronic inflammation of the joints, with Worldwide estimates that 9.6% of men and 18.0% of women aged >60 years have symptomatic OA. Prevalence increases with age, such that OA is expected to be the fourth leading cause of disability by the year 2020 (WHO report, 2003). Thus factors that slow the onset or progression of this disease will significantly benefit the well-being of older people.